Merck KGaA eyes job cuts at drugs unit -paper
FRANKFURT, April 11
FRANKFURT, April 11 (Reuters) - Germany's Merck KGaA (MRCG.DE) is mulling job cuts at prescription drug unit Merck Serono to save costs, the Financial Times Deutschland newspaper reported, citing company sources.
Cutbacks could affect the unit's Swiss headquarters in particular, the paper added.
Stefan Oschmann took over Merck's prescription drug unit Merck Serono on Jan. 1 after the unit saw a string of setbacks in product development.
The European drugs watchdog on Sept. 24 dealt the German family controlled group a blow by advising against the oral multiple-sclerosis treatment cladribine in the drug's potentially largest market. [ID:nLDE68N04J]
Global drugmakers, including Merck & Co (MRK.N), Roche (ROG.VX) and Novartis (NOVN.VX), have announced job cuts as approvals for new products are slowing while key drugs are losing patent protection. (Reporting by Jonathan Gould; Editing by Louise Heavens)
- Tweet this
- Share this
- Digg this
- Exclusive - Apple, Google agree to pay over $300 million to settle conspiracy lawsuit
- Ukraine forces kill up to five rebels, Russia starts drill near border |
- Boy and girl on Korean ferry drowned with life jackets tied together |
- Brazilian Congress passes Internet bill of rights
- Microsoft beats Wall Street on new CEO debut |